"მრავალპროფილური სამედიცინო ცენტრი დაკომპლექტებულია მაღალკვალიფიციური, პროფესიონალი ექიმებით, აღჭურვილია ულტრათანამედროვე აპარატურით, ფლობს მძლავრ მატერიალურ-ტექნიკურ ბაზას და გამორჩეულია მყუდრო, კომფორტული გარემოთი. ფ. თოდუას სამედიცინო ცენტრის უპირატესობა საუკეთესო ექიმებისა და უახლესი აპარატურის კომბინაციაა. სწორედ ეს განაპირობებს მოსახლეობის ნდობასა და ერთგულებას."

During the past decade, LTD Acad. F. Todua Medical Center - LTD Research Institute of Clinical Medicine conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "LTD Acad. F. Todua Medical Center - LTD Research Institute of Clinical Medicine" #1 sponsor was "Biocad" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "UroGen Pharma Ltd." with 2 trials sponsored, "Adiso Therapeutics" with 1 trials sponsored and "Arena Pharmaceuticals" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "LTD Acad. F. Todua Medical Center - LTD Research Institute of Clinical Medicine" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "LTD Acad. F. Todua Medical Center - LTD Research Institute of Clinical Medicine" are "Ulcerative Colitis" (3 trials), "Bladder Cancer" (2 trials), "Urothelial Carcinoma" (2 trials), "Urothelial Carcinoma Bladder" (2 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "LTD Acad. F. Todua Medical Center - LTD Research Institute of Clinical Medicine" in a lesser frequency.

Most popular intervention types in "LTD Acad. F. Todua Medical Center - LTD Research Institute of Clinical Medicine" are "Drug" (12 trials), "Biological" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "BCD-100" (2 trials), "Etrasimod" (2 trials), "Paclitaxel" (2 trials) and "UGN-102" (2 trials). Other intervention names were less common.

The vast majority of trials in "LTD Acad. F. Todua Medical Center - LTD Research Institute of Clinical Medicine" are 10 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "LTD Acad. F. Todua Medical Center - LTD Research Institute of Clinical Medicine". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in LTD Acad. F. Todua Medical Center - LTD Research Institute of Clinical Medicine, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in LTD Acad. F. Todua Medical Center - LTD Research Institute of Clinical Medicine, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".